Citigroup Inc Quotient LTD Transaction History

Citigroup Inc

$169 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 10, 2022	SELL	$0.16 - $0.31 $437 - $848	-2,736 Reduced 98.06%	54 $0
Q2 2022 Aug 10, 2022	SELL	$0.24 - $1.2 $400 - $2,001	-1,668 Reduced 37.42%	2,790 $0
Q1 2022 May 12, 2022	SELL	$0.94 - $2.38 $14,592 - $36,947	-15,524 Reduced 77.69%	4,458 $5,000
Q4 2021 Feb 10, 2022	BUY	$1.89 - $3.12 $16,991 - $28,048	8,990 Added 81.79%	19,982 $52,000
Q3 2021 Nov 10, 2021	BUY	$2.34 - $3.77 $25,721 - $41,439	10,992 New	10,992 $26,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.